Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0280
0.00 (0.00%)
Apr 17, 2026, 2:46 PM AEST
Entropy Neurodynamics Market Cap
Entropy Neurodynamics has a market cap or net worth of 45.28 million as of April 17, 2026. Its market cap has decreased by -4.64% in one year.
Market Cap
45.28M
Enterprise Value
39.52M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since May 29, 2024, Entropy Neurodynamics's market cap has increased from 38.06M to 45.28M, an increase of 18.97%. That is a compound annual growth rate of 9.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 45.28M | -12.02% |
| Dec 31, 2025 | 51.47M | 6.11% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amplia Therapeutics | 84.66M |
| LTR Pharma | 72.71M |
| Radiopharm Theranostics | 72.66M |
| Neurizon Therapeutics | 60.61M |
| Prescient Therapeutics | 53.63M |
| Imugene | 53.55M |
| Proteomics International Laboratories | 45.43M |
| NeuroScientific Biopharmaceuticals | 38.25M |